Abstract:AIM:To investigate the roles of nuclear factor (NF)-κB and angiotensin II receptor type 1 (AT1R) in the pathogenesis of non-alcoholic fatty liver disease (NAFLD).METHODS:Forty-two healthy adult male Sprague-Dawley rats were randomly divided into three groups: the control group (normal diet), the model group, and the intervention group (10 wk of a high-fat diet feeding, followed by an intraperitoneal injection of PDTC); 6 rats in each group were sacrificed at 6, 10, and 14 wk. After sacrifice, liver tissue was taken, paraffin sections of liver tissue specimens were prepared, hematoxylin and eosin (HE) staining was performed, and pathological changes in liver tissue (i.e., liver fibrosis) were observed by light microscopy. NF-κB expression in liver tissue was detected by immunohistochemistry, and the expression of AT1R in the liver tissue was detected by reverse transcription-polymerase chain reaction (RT-PCR). The data are expressed as mean ± SD. A two-sample t test was used to compare the control group and the model group at different time points, paired t tests were used to compare the differences between the intervention group and the model group, and analysis of variance was used to compare the model group with the control group. Homogeneity of variance was analyzed with single factor analysis of variance. H variance analysis was used to compare the variance. P < 0.05 was considered statistically significant.RESULTS:The NAFLD model was successful after 6 wk and 10 wk. Liver fibrosis was found in four rats in the model group, but in only one rat in the intervention group at 14 wk. Liver steatosis, inflammation, and fibrosis were gradually increased throughout the model. In the intervention group, the body mass, rat liver index, serum lipid, and transaminase levels were not increased compared to the model group. In the model group, the degree of liver steatosis was increased at 6, 10, and 14 wk, and was significantly higher than in the control group (P < 0.01). In the model group, different degrees of liver cell necrosis were visible and small leaves, punctated inflammation, focal necrosis, and obvious ballooning degeneration were observed. Partial necrosis and confluent necrosis were observed. In the model group, liver inflammatory activity scores at 6, 10, and 14 wk were higher than in the control group (P < 0.01). Active inflammation in liver tissue in the intervention group was lower than in the model group (P < 0.05). HE staining showed liver fibrosis only at 14 wk in 4/6 rats in the model group and in 1/6 rats in the intervention group. NF-κB positive cells were stained yellow or ensemble yellow, and NF-κB was localized in the cytoplasm and/or nucleus. The model group showed NF-κB activation at 6, 10, and 14 wk in liver cells; at the same time points, there were statistically significant differences in the control group (P < 0.01). Over time, NF-κB expression increased; this was statistically lower (P < 0.05) at 14 weeks in the intervention group compared to the model group, but significantly increased (P < 0.05) compared with the control group; RT-PCR showed that AT1R mRNA expression increased gradually in the model group; at 14 wk, the expression was significantly different compared with expression at 10 weeks as well as at 6 weeks (P < 0.05). In the model group, AT1R mRNA expression was significantly higher than at the same time point in the control group (P < 0.01).CONCLUSION:With increasing severity of NAFLD, NF-κB activity is enhanced, and the inhibition of NF-κB activity may reduce AT1R mRNA expression in NAFLD.

Short-term Exposure to Low Doses of Aflatoxin B1 Aggravates Nonalcoholic Steatohepatitis by TLR4-mediated Necroptosis

AFB1 Induced Transcriptional Regulation Related to Apoptosis and Lipid Metabolism in Liver of Chicken

AFB1-induced Mice Liver Injury Involves Mitochondrial Dysfunction Mediated by Mitochondrial Biogenesis Inhibition

Macrophage AHR-TLR4 cross-talk drives p-STAT3 (Ser727)-mediated mitochondrial oxidative stress and upregulates IDO/ICAM-1 in the steatohepatitis induced by aflatoxin B1

Aflatoxin B1 Induces Liver Injury by Disturbing Gut Microbiota-Bile Acid-Fxr Axis in Mice

Aflatoxin B-1 Invokes Apoptosis Via Death Receptor Pathway in Hepatocytes

The effect of aflatoxin B1 on the expression of early response genes and transforming growth factor-alpha in CCl4 induced rat liver injury

Aflatoxin B1 Exposure in Sheep: Insights into Hepatotoxicity Based on Oxidative Stress, Inflammatory Injury, Apoptosis, and Gut Microbiota Analysis

Aflatoxin B1 Exposure Triggers Hepatic Lipotoxicity Via P53 and Perilipin 2 Interaction-Mediated Mitochondria-Lipid Droplet Contacts: an in Vitro and in Vivo Assessment

Integrated Network Toxicology, Molecular Docking, and in Vivo Experiments to Elucidate Molecular Mechanism of Aflatoxin B1 Hepatotoxicity

Contamination of Aflatoxins Induces Severe Hepatotoxicity Through Multiple Mechanisms

TAF15 exacerbates nonalcoholic steatohepatitis progression by regulating lipid metabolism and inflammation via FASN and p65 NF-κB

Aflatoxin B1-induced early developmental hepatotoxicity in larvae zebrafish

High-Fat Diet Aggravates Acute Pancreatitis Via TLR4-Mediated Necroptosis and Inflammation in Rats

AFB1 Triggers Lipid Metabolism Disorders through the PI3K/Akt Pathway and Mediates Apoptosis Leading to Hepatotoxicity

Aflatoxin B1 Enhances Pyroptosis of Hepatocytes and Activation of Kupffer Cells to Promote Liver Inflammatory Injury Via Dephosphorylation of Cyclooxygenase-2: an in Vitro, Ex Vivo and in Vivo Study

Aflatoxin B 1 -induced liver pyroptosis is mediated by disturbing the gut microbial metabolites: The roles of pipecolic acid and norepinephrine

Role of macrophage AHR/TLR4/STAT3 signaling axis in the colitis induced by non-canonical AHR ligand aflatoxin B1

Non-cytotoxic Dosage of Fumonisin B1 Aggravates Ochratoxin A-induced Nephrocytotoxicity and Apoptosis Via ROS-dependent JNK/MAPK Signaling Pathway

Rab7a-mTORC1 Signaling-Mediated Cholesterol Trafficking from the Lysosome to Mitochondria Ameliorates Hepatic Lipotoxicity Induced by Aflatoxin B1 Exposure

Effect of Nuclear Factor-Κb and Angiotensin II Receptor Type 1 on the Pathogenesis of Rat Non-Alcoholic Fatty Liver Disease.